Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. [electronic resource]
Producer: 20091030Description: 1205-16 p. digitalISSN:- 1179-1950
- Adrenal Cortex Hormones -- therapeutic use
- Adrenergic beta-Agonists -- adverse effects
- Adult
- Aged
- Albuterol -- therapeutic use
- Area Under Curve
- Bronchodilator Agents -- adverse effects
- Drug Therapy, Combination
- Dyspnea -- complications
- Ethanolamines -- adverse effects
- Female
- Forced Expiratory Volume -- physiology
- Formoterol Fumarate
- Humans
- Male
- Middle Aged
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Quality of Life
- Scopolamine Derivatives -- adverse effects
- Spirometry
- Tiotropium Bromide
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.